VAMP4 in hypoxic adipose stem cell exosomes alleviates ischemia-reperfusion injury
Cellular and Molecular Life Sciences · 2025
DOI: 10.1007/s00018-025-05967-4 ↗At a glance
Journal article in Cellular and Molecular Life Sciences, 2025. Written by Yinmin Wang and 5 co-authors. Institution: Department of plastic and reconstructive surgery, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People's Hospital, Shanghai, Chin…. Major MEDLINE topics: Exosomes, Reperfusion Injury, Stem Cells, Adipose Tissue. 31 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Wuxi Taihu Lake Talent Plan, Supports for Leading Talents in Medical and Health Profession, National Nature Youth Foundation of China, Science and Technology Commission of Shanghai Municipality.
Abstract (original language)
BACKGROUND: Ischemia/reperfusion injury (I/RI) impedes the progress of flap and allograft transplantation. Among various strategies to address oxidative stress (OS) and mitochondrial dysfunction associated with I/RI, exosomes derived from adipose-derived stem cells (ADSCs) subjected to hypoxia pretreatment show significant therapeutic potential. METHODS AND RESULTS: This study assessed the effects of ADSC-derived exosomes (ADSC-Ex) from normoxic and hypoxic conditions on reactive oxygen species (ROS), mitochondrial calcium ion (Ca2+) influx, mitochondrial potential, and cell apoptosis in an ischemia/reperfusion (I/R) model. Mass spectrometry (MS) was utilized to analyze differentially expressed proteins in hypoxic ADSC-Ex compared to normoxic controls. The functions of significantly upregulated proteins were investigated through knockdown experiments in hypoxic ADSC-Ex on alleviating I/R injury (I/RI) in HUVECs. Hypoxic ADSC-Ex significantly mitigated I/RI in vascular endothelial cells both in vitro and in vivo. This effect was associated with reduced ROS and mitochondrial Ca2+ influx, and protection of mitochondrial potential. MS identified several proteins that were significantly upregulated in hypoxic ADSC-Ex, with Vesicle-associated membrane protein 4 (VAMP4) emerging as a pivotal molecule involved in alleviating I/RI in vascular endothelial cells. CONCLUSION: This study demonstrated that hypoxic ADSC-Ex reduced ROS and mitochondrial dysfunction in vascular endothelial cells through VAMP4, thereby attenuating I/RI. This finding might provide a new approach for treating post-transplant I/RI.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of plastic and reconstructive surgery, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People's Hospital, Shanghai, China. wangyinmin@sjtu.edu.cn.
- Department of plastic surgery, Affiliated hospital of Jiangnan University, Wuxi, Jiangsu, China.
- Department of plastic and reconstructive surgery, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People's Hospital, Shanghai, China.
Funding
- Wuxi Taihu Lake Talent Plan, Supports for Leading Talents in Medical and Health Profession
- National Nature Youth Foundation of China
- Science and Technology Commission of Shanghai Municipality
Cite
APA
Wang, Y., Yu, S., Wang, X., Jin, R., Liu, F., & Yang, J. (2025). VAMP4 in hypoxic adipose stem cell exosomes alleviates ischemia-reperfusion injury. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-025-05967-4
Vancouver
Wang Y, Yu S, Wang X, Jin R, Liu F, Yang J. VAMP4 in hypoxic adipose stem cell exosomes alleviates ischemia-reperfusion injury. Cellular and Molecular Life Sciences. 2025. doi:10.1007/s00018-025-05967-4
BibTeX
@article{Wang2025,
author = {Wang, Yinmin and Yu, Shun and Wang, Xiuxia and Jin, Rui and Liu, Fei and Yang, Jun},
title = {VAMP4 in hypoxic adipose stem cell exosomes alleviates ischemia-reperfusion injury},
journal = {Cellular and Molecular Life Sciences},
year = {2025},
doi = {10.1007/s00018-025-05967-4}
}
EUVIMED